These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3530849)

  • 1. Renal effects of nicardipine, a calcium entry blocker, in hypertensive type II diabetic patients with nephropathy.
    Baba T; Ishizaki T; Ido Y; Aoyagi K; Murabayashi S; Takebe K
    Diabetes; 1986 Nov; 35(11):1206-14. PubMed ID: 3530849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of nicardipine in patients with mild-to-moderate essential hypertension.
    Baba T; Boku A; Ishizaki T; Sone K; Takebe K
    Am Heart J; 1986 Mar; 111(3):552-7. PubMed ID: 3953366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy.
    Baba T; Tomiyama T; Murabayashi S; Takebe K
    Eur J Clin Pharmacol; 1990; 38(5):425-9. PubMed ID: 2379527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple oral doses of nicardipine, a calcium-entry blocker: effects on renal function, plasma renin activity, and aldosterone concentration in mild-to-moderate essential hypertension.
    Baba T; Ishizaki T; Murabayashi S; Aoyagi K; Tamasawa N; Takebe K
    Clin Pharmacol Ther; 1987 Aug; 42(2):232-9. PubMed ID: 3301155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
    Baba T; Murabayashi S; Takebe K
    Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a calcium-entry blocker, nicardipine, on intrarenal hemodynamics in essential hypertension.
    Kimura G; Deguchi F; Kojima S; Ashida T; Yoshimi H; Abe H; Kawano Y; Yoshida K; Kawamura M; Imanishi M
    Am J Kidney Dis; 1991 Jan; 17(1):47-54. PubMed ID: 1986570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic (systemic and renal) and humoral interactions between nicardipine and domperidone in hypertensives.
    Lucarini AR; Salvetti A
    J Hypertens Suppl; 1987 Dec; 5(5):S571-4. PubMed ID: 3327930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy.
    Stornello M; Valvo EV; Scapellato L
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):851-5. PubMed ID: 2481772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute and chronic effects of a new calcium blocker, nicardipine, on renal hemodynamics in arterial hypertension].
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guédon J
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1642-6. PubMed ID: 3938234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
    Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
    Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic effects of a new calcium inhibitor, nicardipine, on renal hemodynamics in hypertension.
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guedon J
    J Cardiovasc Pharmacol; 1986; 8(5):892-7. PubMed ID: 2429087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nicardipine on the systemic and renal hemodynamics in acutely elevated blood pressure induced by vasoactive agents in conscious rabbits.
    Matsukawa S; Suzuki H; Itaya Y; Kumagai H; Saruta T
    Jpn Heart J; 1987 May; 28(3):435-43. PubMed ID: 3626025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dissociation of hypotensive and renal hemodynamic effects of an angiotensin converting enzyme inhibitor in insulin-dependent diabetic patients with incipient nephropathy].
    Hallab M; Billiard A; Lejeune JJ; Bled F; Girault A; Fressinaud P; Marre M
    Arch Mal Coeur Vaiss; 1991 Mar; 84(3):383-6. PubMed ID: 1828659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of manidipine, a new calcium antagonist, on intrarenal hemodynamics in essential hypertension.
    Murakami K; Kimura G; Imanishi M; Sanai T; Kawano Y; Kojima S; Yoshida K; Abe H; Ashida T; Yoshimi H
    Blood Press Suppl; 1992; 3():114-8. PubMed ID: 1343278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of nicardipine in essential hypertension: differences between acute and chronic therapy.
    Smith SA; Rafiqi EI; Gardener EG; Young MA; Littler WA
    J Hypertens; 1987 Dec; 5(6):693-7. PubMed ID: 3429869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of bunazosin, a new alpha 1-adrenoceptor blocker, in patients with mild-to-moderate essential hypertension.
    Baba T; Tomiyama T; Murabayashi S; Takebe K
    J Cardiovasc Pharmacol; 1990 May; 15(5):826-30. PubMed ID: 1692944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes.
    Hannedouche TP; Delgado AG; Gnionsahe DA; Boitard C; Lacour B; Grünfeld JP
    Kidney Int; 1990 Apr; 37(4):1126-33. PubMed ID: 2188030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.